BIOA
BioAge Labs, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:57 PM EST
4.78USD-6.738%(-0.34)640,564
Pre-marketNov 19, 2026 9:07:30 AM EST
4.6212USD-3.221%(-0.1538)
After-hoursNov 18, 2026 4:26:30 PM EST
4.77USD-0.105%(-0.01)
BIOA News
BioArctic collaborator Novartis terminates agreement ·
PR Newswire+1 source
BioArctic's Nomination Committee appointed ·
PR Newswire+1 source
New clinical data on lecanemab to be presented at CTAD conference 2026 ·
Cision+2 sources
Sales of Leqembi® totaled 32.2 billion yen in the third quarter 2026 ·
Cision+2 sources
UBS initiates BioAge Labs stock coverage at neutral on DME focus ·
Investing.com
BioAge Labs to Present at Upcoming Investor Conferences ·
GlobeNewswire Inc.
First patient treated with Leqembi® (lecanemab) in Sweden ·
Cision+2 sources